Abstract:Treatment with epigallocatechin-3-gallate (EGCG), a polyphenolic compound of green tea, results in activation of p53 and induction of apoptosis in prostate cancer LnCaP cells. However, no direct evidence has delineated the role of p53 and p53-dependent pathways in EGCG-mediated apoptosis. To understand the mechanism of negative growth regulation of prostate cancer cells by EGCG we undertook a genetic approach and generated an isogenic pair of prostate carcinoma cells PC3 (p53-/-) by stably introducing a cDNA encoding wild-type p53. Treatment of the resultant cells, PC3-p53, with EGCG led to, as reported earlier in LnCaP cells, an increase in p53 protein, which exacerbated both G1 arrest and apoptosis. This response was accompanied by an increase in the levels of p21 and Bax. The cells lacking p53 continued to cycle and did not undergo apoptosis upon treatment with similar concentrations of EGCG, thus establishing the action of EGCG in a p53-dependent manner. This observation was revalidated in another prostate cancer LNCaP cells harboring wild-type p53. Inactivation of p53 using small interfering RNA (siRNA) rendered these cells resistant to EGCG-mediated apoptosis. Because p53 activation led to increase in p21 and Bax, we investigated whether these two proteins are important in this process. Ablation of p21 protein by siRNA prevented G1 arrest and apoptosis in PC3-p53 cells. The p53-dependent increase in Bax expression altered the Bax/Bcl-2 ratio and paralleled the activation of caspase 9 and 3 and cleavage of PARP. Transfection of cells with Bax siRNA abolished these effects and inhibited apoptosis but did not affect the accumulation of the cells in G1. In summary, using isogenic cell lines and siRNA, we have clearly demonstrated that EGCG activates growth arrest and apoptosis primarily via p53-dependent pathway that involves the function of both p21 and Bax such that down-regulation of either molecule confers a growth advantage to the cells.

Protein Phosphatase-2A is a Target of Epigallocatechin-3-Gallate and Modulates P53-Bak Apoptotic Pathway

Supplementary Figure 1 from Protein Phosphatase-2A Is a Target of Epigallocatechin-3-Gallate and Modulates p53-Bak Apoptotic Pathway

Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression

Epigallocatechin Gallate Promotes P53 Accumulation and Activity Via the Inhibition of MDM2-mediated P53 Ubiquitination in Human Lung Cancer Cells.

EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction

Ablation of either p21 or Bax prevents p53‐dependent apoptosis induced by green tea polyphenol epigallocatechin‐3‐gallate

(−)-Epigallocatechin-3-gallate Induces Apoptosis in Human Pancreatic Cancer Cells Via PTEN

Epigallocatechin Gallate-Β-lactoglobulin Nanoparticles Improve the Antitumor Activity of EGCG for Inducing Cancer Cell Apoptosis

(-)-Epigallocatechin-3-gallate Induces Non-Apoptotic Cell Death in Human Cancer Cells Via Ros-Mediated Lysosomal Membrane Permeabilization

Epigallocatechin-3-gallate Enhances ER Stress-Induced Cancer Cell Apoptosis by Directly Targeting PARP16 Activity

PPARα activation sensitizes cancer cells to epigallocatechin-3-gallate (EGCG) treatment via suppressing heme oxygenase-1.

The BH3-only protein PUMA is involved in green tea polyphenol-induced apoptosis in colorectal cancer cell lines

Cyclin D1 Degradation and P21 Induction Contribute to Growth Inhibition of Colorectal Cancer Cells Induced by Epigallocatechin-3-gallate

(−)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein

Green tea constituent (−)-Epigallocatechin-3-gallate inhibits hep G2 cell proliferation and induces apoptosis through p53-dependent and fas-mediated pathways

Mechanism of Sensitizing Effect of PPARα Activation on Epigallocatechin-3-gallate (EGCG) in Cancer Cells

Curcumin Inhibits Protein Phosphatases 2A and 5, Leading to Activation of Mitogen-Activated Protein Kinases and Death in Tumor Cells.

(−)‐Epigallocatechin‐3‐gallate Induces Du145 Prostate Cancer Cell Death Via Downregulation of Inhibitor of DNA Binding 2, a Dominant Negative Helix‐loop‐helix Protein

EGR-1/ASPP1 inter-regulatory loop promotes apoptosis by inhibiting cyto-protective autophagy

Penta-1,2,3,4,6-O-galloyl-beta-D-glucose Induces P53 and Inhibits STAT3 in Prostate Cancer Cells in Vitro and Suppresses Prostate Xenograft Tumor Growth in Vivo.

Role of Ku70 and Bax in epigallocatechin-3-gallate-induced apoptosis of A549 cells in vivo.